{"title":"肺炎支原体感染中的Ndv - o凝集素:与肺炎的关系","authors":"R. Pyhälä","doi":"10.1111/J.1699-0463.1976.TB01932.X","DOIUrl":null,"url":null,"abstract":"Agglutinins against human group O erythrocytes modified by the B1 strain of Newcastle disease virus were studied in paired sera of 148 patients with a 4-fold or greater rise in complement-fixing M. pneumoniae antibodies. The proportion of cases with a significant rise in NDV-O agglutinins was higher among the patients with pneumonia than among those with neurological or other clinical manifestations.","PeriodicalId":75410,"journal":{"name":"Acta pathologica et microbiologica Scandinavica. Section B, Microbiology","volume":"37 1","pages":"240-244"},"PeriodicalIF":0.0000,"publicationDate":"2009-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NDV‐O AGGLUTININS IN MYCOPLASMA PNEUMONIAE INFECTIONS: ASSOCIATION WITH PNEUMONIA\",\"authors\":\"R. Pyhälä\",\"doi\":\"10.1111/J.1699-0463.1976.TB01932.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Agglutinins against human group O erythrocytes modified by the B1 strain of Newcastle disease virus were studied in paired sera of 148 patients with a 4-fold or greater rise in complement-fixing M. pneumoniae antibodies. The proportion of cases with a significant rise in NDV-O agglutinins was higher among the patients with pneumonia than among those with neurological or other clinical manifestations.\",\"PeriodicalId\":75410,\"journal\":{\"name\":\"Acta pathologica et microbiologica Scandinavica. Section B, Microbiology\",\"volume\":\"37 1\",\"pages\":\"240-244\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta pathologica et microbiologica Scandinavica. Section B, Microbiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1699-0463.1976.TB01932.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta pathologica et microbiologica Scandinavica. Section B, Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1699-0463.1976.TB01932.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
NDV‐O AGGLUTININS IN MYCOPLASMA PNEUMONIAE INFECTIONS: ASSOCIATION WITH PNEUMONIA
Agglutinins against human group O erythrocytes modified by the B1 strain of Newcastle disease virus were studied in paired sera of 148 patients with a 4-fold or greater rise in complement-fixing M. pneumoniae antibodies. The proportion of cases with a significant rise in NDV-O agglutinins was higher among the patients with pneumonia than among those with neurological or other clinical manifestations.